147 related articles for article (PubMed ID: 25727366)
1. Tolerance of the newborn to antiretroviral drug exposure in utero.
Sibiude J; Warszawski J; Blanche S
Expert Opin Drug Saf; 2015 May; 14(5):643-54. PubMed ID: 25727366
[TBL] [Abstract][Full Text] [Related]
2. Safety of agents used to prevent mother-to-child transmission of HIV: is there any cause for concern?
Thorne C; Newell ML
Drug Saf; 2007; 30(3):203-13. PubMed ID: 17343429
[TBL] [Abstract][Full Text] [Related]
3. [Tolerance of antiretroviral drugs during pregnancy].
Blanche S; Warszawski J
Med Sci (Paris); 2013 Apr; 29(4):383-8. PubMed ID: 23621933
[TBL] [Abstract][Full Text] [Related]
4. Antiretroviral use during pregnancy for treatment or prophylaxis.
Sturt AS; Read JS
Expert Opin Pharmacother; 2011 Aug; 12(12):1875-85. PubMed ID: 21534886
[TBL] [Abstract][Full Text] [Related]
5. Antenatal and neonatal antiretroviral therapy in HIV-infected women and their infants: a review of safety issues.
Thorne C; Newell ML
Med Wieku Rozwoj; 2003; 7(4 Pt 1):425-36. PubMed ID: 15010553
[TBL] [Abstract][Full Text] [Related]
6. Minority HIV-1 drug-resistant mutations and prevention of mother-to-child transmission: perspectives for resource-limited countries.
Samuel R; Paredes R; Parboosing R; Moodley P; Gordon M
AIDS Rev; 2014; 16(4):187-98. PubMed ID: 25300623
[TBL] [Abstract][Full Text] [Related]
7. [The reduction of mother-child transmission of HIV infection in developing countries: potential intervention strategies, obstacles to implementation and perspectives. The Reduction of Mother-Child Transmission of HIV Infection in Africa Group].
Meda N; Msellati P; Welffens-Ekra C; Cartoux M; Leroy V; Van de Perre P; Salamon R
Sante; 1997; 7(2):115-25. PubMed ID: 9273118
[TBL] [Abstract][Full Text] [Related]
8. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F
PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
[TBL] [Abstract][Full Text] [Related]
9. [Reducing perinatal transmission by antiretroviral therapy].
Schmied B
Wien Med Wochenschr; 1998; 148(23-24):550-5. PubMed ID: 10189685
[TBL] [Abstract][Full Text] [Related]
10. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.
Palombi L; Marazzi MC; Voetberg A; Magid NA
AIDS; 2007 Jul; 21 Suppl 4():S65-71. PubMed ID: 17620755
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of HIV-infected pregnant women: prevention of virus transmission and adverse effects in mother and child].
Boer K; Nellen JF; Kreyenbroek ME; Godfried MH
Ned Tijdschr Geneeskd; 2009; 153():B410. PubMed ID: 19785876
[TBL] [Abstract][Full Text] [Related]
12. Genotypic resistance tests for the management of the HIV-infected pregnant woman.
Bassetti D; Cargnel A
Scand J Infect Dis Suppl; 2003; 106():70-4. PubMed ID: 15000589
[TBL] [Abstract][Full Text] [Related]
13. Current treatment strategies, complications and considerations for the use of HIV antiretroviral therapy during pregnancy.
Senise JF; Castelo A; MartÃnez M
AIDS Rev; 2011; 13(4):198-213. PubMed ID: 21975356
[TBL] [Abstract][Full Text] [Related]
14. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
; de Vincenzi I
Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
[TBL] [Abstract][Full Text] [Related]
15. Safety of antiretroviral prophylaxis of perinatal transmission for HIV-infected pregnant women and their infants.
Mofenson LM; Munderi P
J Acquir Immune Defic Syndr; 2002 Jun; 30(2):200-15. PubMed ID: 12045684
[TBL] [Abstract][Full Text] [Related]
16. International recommendations on antiretroviral drugs for treatment of HIV-infected women and prevention of mother-to-child HIV transmission in resource-limited settings: 2006 update.
Dao H; Mofenson LM; Ekpini R; Gilks CF; Barnhart M; Bolu O; Shaffer N
Am J Obstet Gynecol; 2007 Sep; 197(3 Suppl):S42-55. PubMed ID: 17825650
[TBL] [Abstract][Full Text] [Related]
17. Easier said than done: World Health Organization recommendations for prevention of mother-to-child transmission of HIV-areas of concern.
Palombi L; Nielsen-Saines K; Giuliano M; Marazzi MC
AIDS Res Hum Retroviruses; 2011 Aug; 27(8):807-8. PubMed ID: 21142813
[TBL] [Abstract][Full Text] [Related]
18. Prevention of vertical transmission of HIV-1 in resource-limited settings.
Coutsoudis A; Kwaan L; Thomson M
Expert Rev Anti Infect Ther; 2010 Oct; 8(10):1163-75. PubMed ID: 20954881
[TBL] [Abstract][Full Text] [Related]
19. Mother-to-child transmission of HIV-1: advances and controversies of the twentieth centuries.
Scarlatti G
AIDS Rev; 2004; 6(2):67-78. PubMed ID: 15332429
[TBL] [Abstract][Full Text] [Related]
20. [Mother-to-child transmission of HIV infections. Antiviral agents and Cesarean section reduce the risk of transmission].
Bohlin AB; Lindgren S; Lidman K; Sönnerborg A
Lakartidningen; 2000 Jul; 97(28-29):3275-9. PubMed ID: 10997016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
